Australia markets closed

Evoke Pharma, Inc. (EVOK)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
0.5868-0.0179 (-2.96%)
As of 04:00PM EDT. Market open.
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-7,792
-7,792
-8,224
-8,538
-13,155
Stock-based compensation
1,128
1,128
1,459
1,879
1,629
Change in working capital
1,550
1,550
132.409
-5,619
4,896
Accounts receivable
-48.239
-48.239
-329.639
-271.882
0
Inventory
-192.462
-192.462
-103.843
20.946
-236.48
Accounts payable
655.126
655.126
60.284
-527.859
243.356
Other working capital
-4,985
-4,985
-6,596
-12,353
-6,630
Other non-cash items
129.074
129.074
37.025
-105.13
-
Net cash provided by operating activities
-4,985
-4,985
-6,596
-12,353
-6,630
Cash flows from financing activities
Common stock issued
0
0
7,444
14,695
3,596
Other financing activities
-119.296
-119.296
-148.993
-1,311
-
Net cash used provided by (used for) financing activities
-119.296
-119.296
7,295
13,429
9,035
Net change in cash
-5,104
-5,104
698.989
1,076
2,405
Cash at beginning of period
9,844
9,844
9,145
8,069
5,664
Cash at end of period
4,739
4,739
9,844
9,145
8,069
Free cash flow
Operating cash flow
-4,985
-4,985
-6,596
-12,353
-6,630
Free cash flow
-4,985
-4,985
-6,596
-12,353
-6,630